Soricle Device Trial for Tinnitus Relief
ClinicalTrials.gov Studies
Summary
A completed clinical trial evaluated Soricle, a medical device combining transcutaneous vagus nerve stimulation (tVNS) and sound stimulation, for subjective tinnitus relief. Participants were randomized to active treatment or sham control groups in a double-blind manner, using the device daily for 8 weeks. The primary objective assessed improvement in tinnitus symptoms, with safety evaluated throughout the study period.
“This study was conducted to evaluate the efficacy and safety of Soricle, a medical device combining transcutaneous vagus nerve stimulation and sound stimulation, in patients with subjective tinnitus.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registry entry documents a completed randomized controlled trial of the Soricle medical device for subjective tinnitus relief. The trial enrolled participants assigned to active tVNS device, tVNS + sound stimulation device, or sham control groups in a double-blind design. Daily device use over 8 weeks was followed to assess improvement in tinnitus symptoms and safety outcomes.
Healthcare providers and tinnitus researchers may find the trial results of interest for understanding non-invasive neuromodulation approaches to tinnitus management. Medical device manufacturers developing similar vagus nerve stimulation products may reference this trial's methodology and endpoints when designing comparable clinical evaluation programs.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Efficacy and Safety of the Soricle for Subjective Tinnitus Relief
N/A NCT07548320 Kind: NA Apr 23, 2026
Abstract
This study was conducted to evaluate the efficacy and safety of Soricle, a medical device combining transcutaneous vagus nerve stimulation and sound stimulation, in patients with subjective tinnitus.
Participants were randomly assigned to either the active treatment group or a sham control group in a double-blind manner. The device was used daily for 8 weeks.
The primary objective was to assess the improvement in tinnitus symptoms, and safety was evaluated throughout the study period.
Conditions: Tinnitus, Subjective Tinnitus
Interventions: Sham Device, tVNS Device, tVNS + Sound Stimulation Device
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.